Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs
Ryan Allway January 7th, 2021 Psychedelics Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (“Core One“) is pleased to announce the appointment of Dr. Robert E.W. Hancock as Executive Chairman of the Company, effective January 6, 2021. Dr. Hancock is an internationally renowned academic in Microbiology and Immunology –... Read more
Ryan Allway January 7th, 2021 Psychedelics EMPOWER CLINICS INC. (CBDT:CSE)(8EC:Frankfurt)(EPWCF:OTCQB) (“Empower“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased... Read more
Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Red Light Holland Announces $5 Million Bought Deal Equity Financing
Ryan Allway January 7th, 2021 Psychedelics Red Light Holland Corp. (“Red Light Holland”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has... Read more
Ontario Brain Institute Increases Investment in Diamond Therapeutics to Accelerate Innovation in Mental Health
Ryan Allway January 7th, 2021 Psychedelics Emerging psychedelic drug development company Diamond Therapeutics has received new investment from the Ontario Brain Institute (OBI), a not-for-profit organization that accelerates discovery and innovation, benefiting both patients and the economy. An early believer in Diamond’s precision, low-dose approach to psychedelic therapies, OBI... Read more
Red Light Holland Announces Increase in Bought Deal Equity Financing to $8.5 Million
Ryan Allway January 7th, 2021 Psychedelics Red Light Holland Corp. (“Red Light Holland”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has... Read more
Thoughtful Brands Announces Binding Letter of Intent for Reverse-Takeover of Franchise Cannabis
Ryan Allway January 7th, 2021 Psychedelics Thoughtful Brands Inc. (“TBI“) (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) and Franchise Cannabis Corp. (“FCC“) are pleased to announce that they have entered into a binding letter of intent (the “Letter of Intent“), dated January 6, 2021, to consummate a going-public transaction for FCC involving the reverse-takeover of... Read more
Mydecine Innovations Group Shares Intellectual Property Update
Ryan Allway January 7th, 2021 Psychedelics Company files seven provisional patent applications with United States Patent and Trademark Office DENVER, Jan. 07, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the... Read more
Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board
Ryan Allway January 7th, 2021 Psychedelics, Top News La Jolla, California–(Newsfile Corp. – January 7, 2021) –  Tryp Therapeutics (CSE: TRYP) (“Tryp” or the “Company”) a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today it has appointed Dr. William... Read more
Pure Extracts Now Listed on the OTC Markets Under the Symbol PRXTF
Ryan Allway January 7th, 2021 Psychedelics, Top News VANCOUVER, British Columbia, Jan. 07, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL)(OTC: PRXTF)(XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company is pleased to announce that the Company received trading approval from OTC Markets and is now... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )